TC Biopharm (Holdings) Plc
TCBP · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $246,402 | $699,891 | $9,788,502 | $13,931,575 |
| - Cash | $2,463 | $4,808 | $1,567 | $748 |
| + Debt | $1,801 | $2,450 | $15,869 | $2,582 |
| Enterprise Value | $245,740 | $697,533 | $9,802,804 | $13,933,410 |
| Revenue | $0 | $3,845 | $1,979 | $1,979 |
| % Growth | -100% | 94.3% | 0% | – |
| Gross Profit | $0 | $3,845 | $1,979 | $1,979 |
| % Margin | – | 100% | 100% | 100% |
| EBITDA | -$13,609 | $4,482 | -$10,733 | -$5,263 |
| % Margin | – | 116.6% | -542.4% | -266% |
| Net Income | -$5,907 | -$1,314 | -$13,576 | -$5,458 |
| % Margin | – | -34.2% | -686.1% | -275.8% |
| EPS Diluted | -9.56 | -19.12 | -82,488 | -124 |
| % Growth | 50% | 100% | -66,422.6% | – |
| Operating Cash Flow | -$10,545 | -$15,292 | -$5,581 | -$3,432 |
| Capital Expenditures | -$110 | -$241 | -$20 | -$35 |
| Free Cash Flow | -$10,655 | -$15,533 | -$5,601 | -$3,467 |